Fenretinide inhibits the proliferation and migration of human liver cancer HepG2 cells by downregulating the activation of myosin light chain kinase through the p38-MAPK signaling pathway.
- Resource Type
- Article
- Source
- Oncology Reports; Jul2018, Vol. 40 Issue 1, p518-526, 9p
- Subject
- Language
- ISSN
- 1021335X